| __timestamp | Travere Therapeutics, Inc. | United Therapeutics Corporation |
|---|---|---|
| Wednesday, January 1, 2014 | 28203205 | 1288519000 |
| Thursday, January 1, 2015 | 99892000 | 1465761000 |
| Friday, January 1, 2016 | 133591000 | 1598800000 |
| Sunday, January 1, 2017 | 154937000 | 1725300000 |
| Monday, January 1, 2018 | 164246000 | 1627800000 |
| Tuesday, January 1, 2019 | 175338000 | 1448800000 |
| Wednesday, January 1, 2020 | 198321000 | 1483300000 |
| Friday, January 1, 2021 | 227490000 | 1685500000 |
| Saturday, January 1, 2022 | 212018000 | 1936300000 |
| Sunday, January 1, 2023 | 145238000 | 2327500000 |
Unleashing the power of data
In the competitive landscape of biotechnology, United Therapeutics Corporation and Travere Therapeutics, Inc. have showcased contrasting revenue trajectories over the past decade. Since 2014, United Therapeutics has consistently outperformed Travere, with revenues peaking at approximately $2.3 billion in 2023, marking an impressive 80% increase from 2014. In contrast, Travere's revenue journey, while more modest, has seen a steady climb, reaching its zenith in 2021 with a 700% increase from its 2014 figures.
The data reveals a fascinating narrative of growth and resilience. United Therapeutics' revenue surged by 50% from 2019 to 2023, reflecting its robust market strategies and product innovations. Meanwhile, Travere's revenue, despite a dip in 2023, underscores its potential in niche markets. This revenue showdown not only highlights the dynamic nature of the biotech industry but also sets the stage for future financial strategies and market positioning.
Revenue Insights: Zoetis Inc. and United Therapeutics Corporation Performance Compared
Annual Revenue Comparison: Takeda Pharmaceutical Company Limited vs Travere Therapeutics, Inc.
Revenue Showdown: United Therapeutics Corporation vs Genmab A/S
Who Generates More Revenue? United Therapeutics Corporation or Exelixis, Inc.
Comparing Revenue Performance: United Therapeutics Corporation or Lantheus Holdings, Inc.?
United Therapeutics Corporation vs Cytokinetics, Incorporated: Examining Key Revenue Metrics
United Therapeutics Corporation and PTC Therapeutics, Inc.: A Comprehensive Revenue Analysis
United Therapeutics Corporation vs Amphastar Pharmaceuticals, Inc.: Annual Revenue Growth Compared
Breaking Down Revenue Trends: United Therapeutics Corporation vs Celldex Therapeutics, Inc.
Ascendis Pharma A/S vs Travere Therapeutics, Inc.: Examining Key Revenue Metrics
MorphoSys AG vs Travere Therapeutics, Inc.: Annual Revenue Growth Compared
Supernus Pharmaceuticals, Inc. or Travere Therapeutics, Inc.: Who Leads in Yearly Revenue?